Related Experiment Video
Updated: Aug 9, 2026

Three-Dimensional Cell Culture Models to Investigate the Epithelial Barrier in Eosinophilic Esophagitis
Published on: May 10, 2024
[Hypereosinophilic asthma]
1Service de Pneumologie, Centre de Référence des Maladies Orphelines Pulmonaires, Université Claude Bernard, Hôpital Louis Pradel, 69677 Lyon, Bron, Cedex. jean-francois.cordier@chu-lyon.fr
Abstract:
Hypereosinophilic asthma (defined by blood eosinophils > 1 G/L, especially > 1.5 G/L) may be solitary (and often difficult to treat), or a manifestation of a hypereosinophilic disorder of determined cause (parasitic, iatrogenic, allergic bronchopulmonary aspergillosis) or idiopathic (idiopathic chronic eosinophilic pneumonia, Churg-Strauss syndrome, idiopathic hypereosinophilic syndrome). In addition to etiologic treatment when available long term corticosteroids are necessary in a majority of patients.
More Related Videos
08:44Identification and Characterization of Immunogenic RNA Species in HDM Allergens that Modulate Eosinophilic Lung Inflammation
Published on: May 30, 2020
09:58A Reversible, Non-invasive Method for Airway Resistance Measurements and Bronchoalveolar Lavage Fluid Sampling in Mice
Published on: April 13, 2010
Related Concept Videos
Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma I: Introduction
Asthma-II: Pathophysiology and Classification
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Asthma-I: Introduction
Asthma III: Clinical Manifestations
Chronic Obstructive Pulmonary Disease II: Emphysema